Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes
about
Delineation of stage specific expression of Plasmodium falciparum EBA-175 by biologically functional region II monoclonal antibodiesBenchmarking B-cell epitope prediction with quantitative dose-response data on antipeptide antibodies: towards novel pharmaceutical product development.Adenylyl cyclase alpha and cAMP signaling mediate Plasmodium sporozoite apical regulated exocytosis and hepatocyte infection.Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.High Sporozoite Antibody Titers in Conjunction with Microscopically Detectable Blood Infection Display Signatures of Protection from Clinical MalariaAntibodies against thrombospondin-related anonymous protein do not inhibit Plasmodium sporozoite infectivity in vivoExpression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens.Antibody and B cell responses to Plasmodium sporozoites.Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of KenyaBreadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infectionGenetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of PeruAntibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.
P2860
Q28741027-346CCC6D-52D7-426F-ADCC-7456AE7D50AEQ30832446-9BB8DD16-CD11-4F3F-AF9F-04835044372AQ33326989-3CC511D0-593E-4FB6-AA01-1738CB8E2F0CQ33512110-7C18B29D-484D-4026-BF65-9D5059EB0D0DQ33577093-5CE35C32-A9EF-41DC-863B-DF5589AFEEA8Q33646573-6536FFDC-7B23-4C88-BE1E-673DF197D906Q34004839-799B37B3-DEF2-4837-9181-5BCD6C248C41Q34006127-A9FC1AF3-79A2-4B94-8C62-0F6AFE46C6BCQ34351117-A77F5DE5-8110-4279-BBFD-1BFE647B7ADDQ34530938-6541F73C-0530-4B9A-A33D-FEE151F6F7C6Q34573891-58996C82-CEE0-4840-AD0A-E5C24BF590D0Q35165581-12706CF4-9AEA-4989-9780-D7708C8B9374Q36004060-8DDFEEC3-5F40-4937-8435-67CB4C1ADBC1Q36728804-2DFF30F8-D23B-49F2-B2C2-F5280FB81F7FQ37023939-FACC5FE6-E28A-4ADE-8B01-61A8D106CE34Q37643867-FB491089-E3B8-4E49-B833-FED4025E4AAC
P2860
Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Development of two monoclonal ...... and mapping of B-cell epitopes
@ast
Development of two monoclonal ...... and mapping of B-cell epitopes
@en
type
label
Development of two monoclonal ...... and mapping of B-cell epitopes
@ast
Development of two monoclonal ...... and mapping of B-cell epitopes
@en
prefLabel
Development of two monoclonal ...... and mapping of B-cell epitopes
@ast
Development of two monoclonal ...... and mapping of B-cell epitopes
@en
P2093
P2860
P1476
Development of two monoclonal ...... and mapping of B-cell epitopes
@en
P2093
Andersen E
Charoenvit Y
Corradin G
De la Vega P
Fallarme V
Houghten RA
P2860
P304
P407
P577
1997-08-01T00:00:00Z